FY 2026 saw record revenue, cash generation, and market leadership, with strong growth in both domestic and international markets. Strategic milestones included onshore manufacturing, proprietary IP development, and a digital health initiative, positioning for accelerated growth in FY 2027.

Based on

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.